Lewis A Hall

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Keith John Roberts · 8 shared papers, 2021–2026 · strength 1.77
   • Paper Pancreatic Cancer in the Holobiont and Therapeutic Targets: A Review. DOI 10.3390/jcm15093225↗
   • Paper Colonization of bile with gammaproteobacteria is associated with reduced survival after surgery for pancreatic cancer i… DOI 10.1016/j.ejso.2026.111396↗
   • Paper Intranetwork variation in neoadjuvant therapy delivery for borderline resectable and locally advanced pancreatic cancer… DOI 10.1308/rcsann.2026.0023↗
2. James Michael Halle-Smith · 6 shared papers, 2021–2026 · strength 1.25
   • Paper Pancreatic Cancer in the Holobiont and Therapeutic Targets: A Review. DOI 10.3390/jcm15093225↗
   • Paper Factors associated with favourable pathological tumour response after neoadjuvant chemotherapy in patients with pancrea… DOI 10.1016/j.hpb.2024.09.002↗
   • Paper Involvement of the Gut Microbiome in the Local and Systemic Immune Response to Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers16050996↗
3. Sarah F. Powell-Brett · 5 shared papers, 2023–2026 · strength 1.03
   • Paper Intranetwork variation in neoadjuvant therapy delivery for borderline resectable and locally advanced pancreatic cancer… DOI 10.1308/rcsann.2026.0023↗
   • Paper Involvement of the Gut Microbiome in the Local and Systemic Immune Response to Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers16050996↗
   • Paper Recent Advances in Pancreatic Ductal Adenocarcinoma: Strategies to Optimise the Perioperative Nutritional Status in Pan… DOI 10.3390/cancers15092466↗
4. Nikolaos A. Chatzizacharias · 4 shared papers, 2024–2026 · strength 0.91
   • Paper Colonization of bile with gammaproteobacteria is associated with reduced survival after surgery for pancreatic cancer i… DOI 10.1016/j.ejso.2026.111396↗
   • Paper Intranetwork variation in neoadjuvant therapy delivery for borderline resectable and locally advanced pancreatic cancer… DOI 10.1308/rcsann.2026.0023↗
   • Paper Factors associated with favourable pathological tumour response after neoadjuvant chemotherapy in patients with pancrea… DOI 10.1016/j.hpb.2024.09.002↗
5. Shivan Sivakumar · 3 shared papers, 2026 · strength 0.71
   • Paper Pancreatic Cancer in the Holobiont and Therapeutic Targets: A Review. DOI 10.3390/jcm15093225↗
   • Paper Intranetwork variation in neoadjuvant therapy delivery for borderline resectable and locally advanced pancreatic cancer… DOI 10.1308/rcsann.2026.0023↗
   • Paper Intention to treat outcomes following management of locally advanced pancreatic ductal adenocarcinoma with curative int… DOI 10.1016/j.hpb.2026.06.008↗
6. Charlotte Terry · 2 shared papers, 2026 · strength 0.58
   • Paper Pancreatic Cancer in the Holobiont and Therapeutic Targets: A Review. DOI 10.3390/jcm15093225↗
   • Paper Colonization of bile with gammaproteobacteria is associated with reduced survival after surgery for pancreatic cancer i… DOI 10.1016/j.ejso.2026.111396↗
7. Nabeel Merali · 2 shared papers, 2023–2026 · strength 0.47
   • Paper Colonization of bile with gammaproteobacteria is associated with reduced survival after surgery for pancreatic cancer i… DOI 10.1016/j.ejso.2026.111396↗
   • Paper Pancreatic Exocrine Insufficiency and the Gut Microbiome in Pancreatic Cancer: A Target for Future Diagnostic Tests and… DOI 10.3390/cancers15215140↗
8. Adam Enver Frampton · 2 shared papers, 2023–2026 · strength 0.47
   • Paper Colonization of bile with gammaproteobacteria is associated with reduced survival after surgery for pancreatic cancer i… DOI 10.1016/j.ejso.2026.111396↗
   • Paper Pancreatic Exocrine Insufficiency and the Gut Microbiome in Pancreatic Cancer: A Target for Future Diagnostic Tests and… DOI 10.3390/cancers15215140↗
9. David Christopher Bartlett · 2 shared papers, 2026 · strength 0.46
   • Paper Colonization of bile with gammaproteobacteria is associated with reduced survival after surgery for pancreatic cancer i… DOI 10.1016/j.ejso.2026.111396↗
   • Paper Intention to treat outcomes following management of locally advanced pancreatic ductal adenocarcinoma with curative int… DOI 10.1016/j.hpb.2026.06.008↗
10. Robert Peter Sutcliffe · 2 shared papers, 2026 · strength 0.46
    • Paper Colonization of bile with gammaproteobacteria is associated with reduced survival after surgery for pancreatic cancer i… DOI 10.1016/j.ejso.2026.111396↗
    • Paper Intention to treat outcomes following management of locally advanced pancreatic ductal adenocarcinoma with curative int… DOI 10.1016/j.hpb.2026.06.008↗
11. S.S. Raza · 2 shared papers, 2026 · strength 0.46
    • Paper Colonization of bile with gammaproteobacteria is associated with reduced survival after surgery for pancreatic cancer i… DOI 10.1016/j.ejso.2026.111396↗
    • Paper Intention to treat outcomes following management of locally advanced pancreatic ductal adenocarcinoma with curative int… DOI 10.1016/j.hpb.2026.06.008↗
12. Peter Lawrence Zaki Labib · 2 shared papers, 2026 · strength 0.41
    • Paper Intranetwork variation in neoadjuvant therapy delivery for borderline resectable and locally advanced pancreatic cancer… DOI 10.1308/rcsann.2026.0023↗
    • Paper Intention to treat outcomes following management of locally advanced pancreatic ductal adenocarcinoma with curative int… DOI 10.1016/j.hpb.2026.06.008↗
13. Moath Alarabiyat · 2 shared papers, 2026 · strength 0.41
    • Paper Intranetwork variation in neoadjuvant therapy delivery for borderline resectable and locally advanced pancreatic cancer… DOI 10.1308/rcsann.2026.0023↗
    • Paper Intention to treat outcomes following management of locally advanced pancreatic ductal adenocarcinoma with curative int… DOI 10.1016/j.hpb.2026.06.008↗
14. Paul A. H. Moss · 2 shared papers, 2023–2024 · strength 0.41
    • Paper Involvement of the Gut Microbiome in the Local and Systemic Immune Response to Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers16050996↗
    • Paper Pancreatic Exocrine Insufficiency and the Gut Microbiome in Pancreatic Cancer: A Target for Future Diagnostic Tests and… DOI 10.3390/cancers15215140↗
15. Hayden Pearce · 1 shared paper, 2024 · strength 0.22
    • Paper Involvement of the Gut Microbiome in the Local and Systemic Immune Response to Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers16050996↗
16. Oonagh M. Griffin · 1 shared paper, 2023 · strength 0.20
    • Paper Recent Advances in Pancreatic Ductal Adenocarcinoma: Strategies to Optimise the Perioperative Nutritional Status in Pan… DOI 10.3390/cancers15092466↗
17. Lois A. Daamen · 1 shared paper, 2021 · strength 0.12
    • Paper Clinical benefit of surveillance after resection of pancreatic ductal adenocarcinoma: A systematic review and meta-anal… DOI 10.1016/j.ejso.2021.04.031↗
18. Ángela Lamarca · 1 shared paper, 2021 · strength 0.12
    • Paper Clinical benefit of surveillance after resection of pancreatic ductal adenocarcinoma: A systematic review and meta-anal… DOI 10.1016/j.ejso.2021.04.031↗
19. Izaak Quintus Molenaar · 1 shared paper, 2021 · strength 0.12
    • Paper Clinical benefit of surveillance after resection of pancreatic ductal adenocarcinoma: A systematic review and meta-anal… DOI 10.1016/j.ejso.2021.04.031↗
20. Nigel Balfour Jamieson · 1 shared paper, 2021 · strength 0.12
    • Paper Clinical benefit of surveillance after resection of pancreatic ductal adenocarcinoma: A systematic review and meta-anal… DOI 10.1016/j.ejso.2021.04.031↗
21. Rupaly Pandé · 1 shared paper, 2021 · strength 0.12
    • Paper Clinical benefit of surveillance after resection of pancreatic ductal adenocarcinoma: A systematic review and meta-anal… DOI 10.1016/j.ejso.2021.04.031↗
22. Hjalmar C. van Santvoort · 1 shared paper, 2021 · strength 0.12
    • Paper Clinical benefit of surveillance after resection of pancreatic ductal adenocarcinoma: A systematic review and meta-anal… DOI 10.1016/j.ejso.2021.04.031↗
23. Juan W. Valle · 1 shared paper, 2021 · strength 0.12
    • Paper Clinical benefit of surveillance after resection of pancreatic ductal adenocarcinoma: A systematic review and meta-anal… DOI 10.1016/j.ejso.2021.04.031↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.